Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Davies M, Færch L, Jeppesen OK, et al.
Lancet. 2021;S0140-6736(21)00213-0
Leggi